Dr. Scagliotti Discusses the Future of Lung Cancer Therapy

Giorgio V. Scagliotti, MD, PhD, head of the Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, believes that making a molecular diagnosis in solid tumors will become readily available in the future, not only in academic centers but also in the community setting. Molecular information will become critical in order to tailor systemic therapies to solid tumors, similar to how it is already being used in the field of hematologic malignancies.